Literature DB >> 10859073

Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation.

D Shibata1, J G Guillem, N Lanouette, P Paty, B Minsky, L Harrison, W D Wong, A Cohen.   

Abstract

PURPOSE: Locally advanced primary and recurrent rectal cancers treated with external beam radiation therapy, intraoperative radiation therapy, and chemotherapy represent a complex group of patients in the setting of extensive pelvic surgery and sphincter preservation. We sought to define functional outcome and quality of life in this subset of patients.
METHODS: We retrospectively reviewed our experience with locally advanced primary and recurrent rectal cancer patients who underwent intraoperative radiation therapy with either low anterior resection (n = 12) or coloanal anastomosis (n = 6) between 1991 and 1998. Current functional outcome and quality of life were evaluated by a detailed questionnaire.
RESULTS: Median time from operation to assessment was 24 (range, 6-93) months. Using a standardized Sphincter Function Scale, incorporating the number of bowel movements per day and degree of incontinence, patients were graded as poor, fair, good, or excellent function. Of all patients, 56 percent reported unfavorable (poor or fair) function. Of the subset of patients with coloanal anastomosis or very low low anterior resection, 88 percent had unfavorable function as compared with 30 percent with standard low anterior resection. (P = 0.02; Fisher's exact probability test). A quality-of-life satisfaction score based on social, professional, and recreational restrictions demonstrated 56 percent of patients to be dissatisfied with their bowel function.
CONCLUSIONS: The majority of patients with advanced rectal cancers who require external beam radiation therapy, extensive pelvic surgery, and intraoperative radiation therapy report unfavorable functional and quality-of-life outcomes after sphincter preservation. In this setting patients being considered for coloanal anastomosis or very low anterior resection may be better served by permanent diversion.

Entities:  

Mesh:

Year:  2000        PMID: 10859073     DOI: 10.1007/bf02238009

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

1.  Risk factors for persistent anal incontinence after restorative proctectomy in rectal cancer patients with anal incontinence: prospective cohort study.

Authors:  Taek-Gu Lee; Sung-Bum Kang; Seung Chul Heo; Seung-Yong Jeong; Kyu Joo Park
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

2.  The long-term impact of hyperthermic intraperitoneal chemotherapy on survivors treated for peritoneal carcinomatosis: a cross-sectional study.

Authors:  Franck Zenasni; Marion Botella; Dominique Elias; Sarah Dauchy; Valérie Boige; David Malka; Michel Ducreux; Jean-Pierre Pignon; Diane Goéré; Marc Pocard
Journal:  Support Care Cancer       Date:  2009-02-06       Impact factor: 3.603

3.  Chemotherapy Alone for Patients With Stage II/III Rectal Cancer Undergoing Radical Surgery.

Authors:  Samy M AlGizawy; Hoda H Essa; Badawy M Ahmed
Journal:  Oncologist       Date:  2015-06-03

4.  Patient expectations of functional outcomes after rectal cancer surgery: a qualitative study.

Authors:  Jason Park; Heather B Neuman; Antonia V Bennett; Lily Polskin; P Terry Phang; W Douglas Wong; Larissa K Temple
Journal:  Dis Colon Rectum       Date:  2014-02       Impact factor: 4.585

5.  Management of a locally advanced rectal cancer in a patient who declined surgery.

Authors:  Raafat Alameddine; David Wehbe; Martin Weiser; Neil Segal; Karyn Goodman; Ali Shamseddine; Celina Ang; Ali Haydar; Mustafa Sidani; Fady Geara; Mohamed Naghy; Eileen M O'Reilly; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2012-11

6.  Development and validation of a colorectal functional outcome questionnaire.

Authors:  Roel Bakx; Mirjam A G Sprangers; Frans J Oort; Willem F van Tets; Willem A Bemelman; J Frederik M Slors; J Jan B van Lanschot
Journal:  Int J Colorectal Dis       Date:  2004-09-22       Impact factor: 2.571

7.  Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients.

Authors:  Alexander P Pietsch; Rainer Fietkau; Günther Klautke; Thomas Foitzik; Ernst Klar
Journal:  Int J Colorectal Dis       Date:  2007-05-12       Impact factor: 2.571

Review 8.  Postoperative Bowel Function After Anal Sphincter-Preserving Rectal Cancer Surgery: Risks Factors, Diagnostic Modalities, and Management.

Authors:  Chris George Cura Pales; Sanghyun An; Jan Paolo Cruz; Kwangmin Kim; Youngwan Kim
Journal:  Ann Coloproctol       Date:  2019-08-31

9.  In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer.

Authors:  Jun-xin Wu; Yu Wang; Na Chen; Lu-chuan Chen; Peng-gang Bai; Jian-ji Pan
Journal:  Radiat Oncol       Date:  2014-07-22       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.